Keynote Panel Discussion – From Adverse Event Reporting to Meaningful Patient Safety: Putting the Patient at the Centre of Modern Pharmacovigilance

Name: Keynote Panel Discussion – From Adverse Event Reporting to Meaningful Patient Safety: Putting the Patient at the Centre of Modern Pharmacovigilance
Start: 2027-03-10T11:30
Location: Sheraton Skyline Hotel London Heathrow

Pharmacovigilance UK & EU 2027 · 10 March 2027 · 11:30

Keynote Panel Discussion – From Adverse Event Reporting to Meaningful Patient Safety: Putting the Patient at the Centre of Modern Pharmacovigilance was a session at Pharmacovigilance UK & EU 2027 on 10 March 2027 in London, with 5 speakers on record.

Speakers

Pav Rishiraj — Moderator Director, Head of Pharmacovigilance, Ipsen
Fabio De Gregorio — Panelist Vice President, Global Patient Safety, TA Rare Diseases Head, Ipsen
Tanuja Halady — Panelist Senior Medical Director, Head of GPS Oncology Group III at Merck KGaA, Darmstadt, Germany, Merck KGaA, Darmstadt, Germany
Petar Gjorgiev — Panelist Global Patient Safety Lead, Regeneron
Naomi Litchfield — Panelist Director Patient Advocacy, Bionical Emas